Publicaciones en colaboración con investigadores/as de King's College London (10)

2024

  1. Progress in the Treatment of Alzheimer’s Disease Is Needed – Position Statement of European Alzheimer’s Disease Consortium (EADC) Investigators

    Journal of Prevention of Alzheimer's Disease

2023

  1. The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside

    Nature Reviews Neurology, Vol. 19, Núm. 8, pp. 489-505

2021

  1. Iron and inflammation: in vivo and post-mortem studies in Parkinson’s disease

    Journal of Neural Transmission, Vol. 128, Núm. 1, pp. 15-25

  2. Longitudinal changes in movement-related functional MRI activity in Parkinson's disease patients

    Parkinsonism and Related Disorders, Vol. 87, pp. 61-69

2018

  1. 11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study

    Movement Disorders, Vol. 33, Núm. 1, pp. 117-127

2017

  1. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility

    European Journal of Neurology, Vol. 24, Núm. 2, pp. 357-365

2015

  1. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches

    Movement Disorders, Vol. 30, Núm. 2, pp. 150-159

2005

  1. Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination

    Neurologia, Vol. 20, Núm. 4, pp. 180-188

1999

  1. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease

    Annals of Neurology, Vol. 45, Núm. 4, pp. 473-488

1995

  1. The rationale for the use of dopamine agonists in parkinson's disease

    Neurology, Vol. 45, Núm. 3, pp. S6-S12